These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19357005)

  • 21. Characterization of a novel calcium phosphate/sulphate bone cement.
    Nilsson M; Fernández E; Sarda S; Lidgren L; Planell JA
    J Biomed Mater Res; 2002 Sep; 61(4):600-7. PubMed ID: 12115450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of added gelatin on the properties of calcium phosphate cement.
    Bigi A; Bracci B; Panzavolta S
    Biomaterials; 2004 Jun; 25(14):2893-9. PubMed ID: 14962568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer--calcium phosphate cement composites for bone substitutes.
    Mickiewicz RA; Mayes AM; Knaack D
    J Biomed Mater Res; 2002 Sep; 61(4):581-92. PubMed ID: 12115448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel doped calcium phosphate-PMMA bone cement composites as levofloxacin delivery systems.
    Matos AC; Marques CF; Pinto RV; Ribeiro IA; Gonçalves LM; Vaz MA; Ferreira JM; Almeida AJ; Bettencourt AF
    Int J Pharm; 2015 Jul; 490(1-2):200-8. PubMed ID: 26002570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering.
    Guo H; Su J; Wei J; Kong H; Liu C
    Acta Biomater; 2009 Jan; 5(1):268-78. PubMed ID: 18722167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement.
    Barralet JE; Gaunt T; Wright AJ; Gibson IR; Knowles JC
    J Biomed Mater Res; 2002; 63(1):1-9. PubMed ID: 11787022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Processing and in vivo evaluation of multiphasic calcium phosphate cements with dual tricalcium phosphate phases.
    Lopez-Heredia MA; Bongio M; Bohner M; Cuijpers V; Winnubst LA; van Dijk N; Wolke JG; van den Beucken JJ; Jansen JA
    Acta Biomater; 2012 Sep; 8(9):3500-8. PubMed ID: 22659172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cephalexin-loaded injectable macroporous calcium phosphate bone cement.
    Hesaraki S; Nemati R
    J Biomed Mater Res B Appl Biomater; 2009 May; 89(2):342-352. PubMed ID: 18823021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium phosphate cement reinforcement by polymer infiltration and in situ curing: a method for 3D scaffold reinforcement.
    Alge DL; Chu TM
    J Biomed Mater Res A; 2010 Aug; 94(2):547-55. PubMed ID: 20186776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-strength, in situ-setting calcium phosphate composite with protein release.
    Weir MD; Xu HH
    J Biomed Mater Res A; 2008 May; 85(2):388-96. PubMed ID: 17688288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate.
    Mavis B; Demirtaş TT; Gümüşderelioğlu M; Gündüz G; Colak U
    Acta Biomater; 2009 Oct; 5(8):3098-111. PubMed ID: 19426840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of dicalcium phosphate dihydrate cements prepared using a novel hydroxyapatite-based formulation.
    Alge DL; Santa Cruz G; Goebel WS; Chu TM
    Biomed Mater; 2009 Apr; 4(2):025016. PubMed ID: 19349655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a porosity measurement method for wet calcium phosphate cements.
    Ajaxon I; Maazouz Y; Ginebra MP; Öhman C; Persson C
    J Biomater Appl; 2015 Nov; 30(5):526-36. PubMed ID: 26163278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Of the in vivo behavior of calcium phosphate cements and glasses as bone substitutes.
    Sanzana ES; Navarro M; Macule F; Suso S; Planell JA; Ginebra MP
    Acta Biomater; 2008 Nov; 4(6):1924-33. PubMed ID: 18539102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of antifungal agents using bioactive and nonbioactive bone cements.
    Sealy PI; Nguyen C; Tucci M; Benghuzzi H; Cleary JD
    Ann Pharmacother; 2009 Oct; 43(10):1606-15. PubMed ID: 19755620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-TCP cements prepared by syringe-foaming: Influence of Na
    Vásquez AF; Domínguez S; Loureiro Dos Santos LA
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():148-155. PubMed ID: 28887959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro surface reaction layer formation and dissolution of calcium phosphate cement-bioactive glass composites.
    Liu C; Chen CW; Ducheyne P
    Biomed Mater; 2008 Sep; 3(3):034111. PubMed ID: 18689928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of strontium and gelatin on the reactivity of alpha-tricalcium phosphate.
    Boanini E; Panzavolta S; Rubini K; Gandolfi M; Bigi A
    Acta Biomater; 2010 Mar; 6(3):936-42. PubMed ID: 19819353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone substitute: transforming beta-tricalcium phosphate porous scaffolds into monetite.
    Galea LG; Bohner M; Lemaître J; Kohler T; Müller R
    Biomaterials; 2008; 29(24-25):3400-7. PubMed ID: 18495242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro degradation and fracture toughness of multilayered porous poly(propylene fumarate)/beta-tricalcium phosphate scaffolds.
    Wolfe MS; Dean D; Chen JE; Fisher JP; Han S; Rimnac CM; Mikos AG
    J Biomed Mater Res; 2002 Jul; 61(1):159-64. PubMed ID: 12001259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.